Acorda Therapeutics, Inc. (ACOR)

NASDAQ: ACOR · IEX Real-Time Price · USD
15.09
+0.10 (0.67%)
At close: Dec 29, 2023, 4:00 PM
15.50
+0.41 (2.72%)
After-hours: Dec 29, 2023, 7:56 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2002
Revenue
118.57129.07152.97192.41471.43588.29519.6492.66401.48336.43
Upgrade
Revenue Growth (YoY)
-8.14%-15.62%-20.50%-59.19%-19.86%13.22%5.47%22.71%19.34%10.01%
Upgrade
Cost of Revenue
30.3340.7933.5134.8597.64111.96108.1192.9380.6266.64
Upgrade
Gross Profit
88.2388.28119.45157.56373.79476.33411.49399.73320.87269.79
Upgrade
Selling, General & Admin
106.26124.4152.58192.85172.25181.62235.44205.63201.81185.55
Upgrade
Research & Development
5.810.4223.0160.08106.38166.11203.44149.2173.4753.88
Upgrade
Other Operating Expenses
18.2130.7692.79303.21.67320.52-9.9-0.416.990
Upgrade
Operating Expenses
130.27165.58268.38556.13280.31668.25428.97354.43282.27239.42
Upgrade
Operating Income
-42.04-77.3-148.92-398.5793.49-191.91-17.4845.338.5930.37
Upgrade
Interest Expense / Income
30.230.0430.5721.8721.618.6616.5315.479.292.17
Upgrade
Other Expense / Income
-36.991.74-71.83-146.1951.4741.317.2810.461.29-0.67
Upgrade
Pretax Income
-35.25-109.07-107.67-274.2520.42-251.89-41.2819.3728.0128.86
Upgrade
Income Tax
30.67-5.12-8.07-1.28-13.26-28.53-6.678.3110.3412.42
Upgrade
Net Income
-65.92-103.95-99.59-272.9733.68-223.36-34.6211.0617.6716.44
Upgrade
Net Income Growth
--------37.43%7.49%-89.39%
Upgrade
Shares Outstanding (Basic)
1100000000
Upgrade
Shares Outstanding (Diluted)
1100000000
Upgrade
Shares Change
85.55%31.38%1.98%0.47%2.92%1.64%3.76%2.53%2.07%3.35%
Upgrade
EPS (Basic)
-66.80-195.80-246.40-688.6086.40-583.20-91.2031.2051.6049.20
Upgrade
EPS (Diluted)
-66.80-195.80-246.40-688.6085.20-583.20-91.2030.0050.4046.80
Upgrade
EPS Growth
--------40.48%7.69%-89.84%
Upgrade
Free Cash Flow
-21.06-41.51-65.4-218.59117.4783.4523.4632.5669.5735.24
Upgrade
Free Cash Flow Per Share
-21.37-78.17-161.79-551.51299.85217.6962.1992.52202.86105.18
Upgrade
Gross Margin
74.42%68.40%78.09%81.89%79.29%80.97%79.19%81.14%79.92%80.19%
Upgrade
Operating Margin
-35.45%-59.89%-97.36%-207.15%19.83%-32.62%-3.36%9.20%9.61%9.03%
Upgrade
Profit Margin
-55.59%-80.54%-65.11%-141.87%7.14%-37.97%-6.66%2.24%4.40%4.89%
Upgrade
Free Cash Flow Margin
-17.76%-32.16%-42.75%-113.61%24.92%14.18%4.51%6.61%17.33%10.48%
Upgrade
Effective Tax Rate
-----64.92%--42.91%36.91%43.04%
Upgrade
EBITDA
27.76-45.09-35.8-217.853.5-209.99-3.1749.8545.7738.03
Upgrade
EBITDA Margin
23.41%-34.93%-23.40%-113.20%11.35%-35.69%-0.61%10.12%11.40%11.30%
Upgrade
Depreciation & Amortization
32.8133.9541.334.5711.4823.2321.5815.018.477
Upgrade
EBIT
-5.05-79.04-77.09-252.3842.02-233.22-24.7634.8437.331.03
Upgrade
EBIT Margin
-4.26%-61.24%-50.40%-131.17%8.91%-39.64%-4.76%7.07%9.29%9.22%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).